Ionis Pharmaceuticals | IONS - 应收帐款人



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.22B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


应收帐款人 更改 日
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Arrowhead Research USD 8.56M 7.13M 2026-06
Astellas Pharma JPY 844.8B 83.04B 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Exelixis USD 322.21M 6.73M 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Omeros USD 8.08M 440K 2024-06
OPKO Health USD 107.62M 18.49M 2026-03
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 53K 14K 2025-12
Pfizer USD 16.19B 19M 2026-06
Pharma Mar EUR 58.06M 6.87M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Qiagen NV USD 398.35M 1.73M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03